Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5727
Gene Symbol: PTCH1
PTCH1 		0.600 CausalMutation disease CGI
Entrez Id: 6608
Gene Symbol: SMO
SMO 		0.320 CausalMutation disease CGI
Entrez Id: 7507
Gene Symbol: XPA
XPA 		0.320 CausalMutation disease CGI
Entrez Id: 2068
Gene Symbol: ERCC2
ERCC2 		0.310 CausalMutation disease CGI
Entrez Id: 1643
Gene Symbol: DDB2
DDB2 		0.300 CausalMutation disease CGI
Entrez Id: 2071
Gene Symbol: ERCC3
ERCC3 		0.300 CausalMutation disease CGI
Entrez Id: 6777
Gene Symbol: STAT5B
STAT5B 		0.300 CausalMutation disease CGI
Entrez Id: 2072
Gene Symbol: ERCC4
ERCC4 		0.300 CausalMutation disease CGI
Entrez Id: 2073
Gene Symbol: ERCC5
ERCC5 		0.300 CausalMutation disease CGI
Entrez Id: 5921
Gene Symbol: RASA1
RASA1 		0.300 CausalMutation disease CGI
Entrez Id: 7508
Gene Symbol: XPC
XPC 		0.300 CausalMutation disease CGI
Entrez Id: 6608
Gene Symbol: SMO
SMO 		0.320 AlteredExpression disease LHGDN Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. 12499255 2002
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.130 AlteredExpression disease LHGDN Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors. 15492790 2004
Entrez Id: 2735
Gene Symbol: GLI1
GLI1 		0.030 AlteredExpression disease LHGDN Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. 16434164 2006
Entrez Id: 2735
Gene Symbol: GLI1
GLI1 		0.030 AlteredExpression disease LHGDN Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma. 12907651 2003
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.020 AlteredExpression disease LHGDN p16 gene expression in basal cell carcinoma. 18760195 2008
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.020 AlteredExpression disease LHGDN Invade or proliferate? Two contrasting events in malignant behavior governed by p16(INK4a) and an intact Rb pathway illustrated by a model system of basal cell carcinoma. 12702553 2003
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA 		0.020 AlteredExpression disease LHGDN CD34 microvessel density and VEGF expression in basal and squamous cell carcinoma. 14708636 2003
Entrez Id: 6277
Gene Symbol: S100A6
S100A6 		0.010 AlteredExpression disease LHGDN Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays. 18201235 2008
Entrez Id: 8626
Gene Symbol: TP63
TP63 		0.010 AlteredExpression disease LHGDN CUSP/p63 expression in basal cell carcinoma. 12102658 2002
Entrez Id: 8549
Gene Symbol: LGR5
LGR5 		0.010 AlteredExpression disease LHGDN G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation. 18688030 2008
Entrez Id: 5578
Gene Symbol: PRKCA
PRKCA 		0.010 AlteredExpression disease LHGDN Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma. 12907651 2003
Entrez Id: 4170
Gene Symbol: MCL1
MCL1 		0.010 AlteredExpression disease LHGDN The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells. 12445202 2002
Entrez Id: 3569
Gene Symbol: IL6
IL6 		0.010 AlteredExpression disease LHGDN The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells. 12445202 2002
Entrez Id: 3880
Gene Symbol: KRT19
KRT19 		0.010 AlteredExpression disease LHGDN Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas. 18095993 2008